A long-term review of the treatment of patients with Ewing's sarcoma in one institution.

  title={A long-term review of the treatment of patients with Ewing's sarcoma in one institution.},
  author={Maria Celeste Sluga and Reinhard Windhager and Susanna Lang and Harald Heinzl and Petra Krepler and Florian Mittermayer and Martin Dominkus and Andreas Zoubek and Rainer Kotz},
  journal={European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology},
  volume={27 6},
AIMS The treatment of patients suffering from Ewing's sarcoma has changed over the last three decades. We report the analyses, significant prognostic factors, interdisciplinary approach and development of therapy in one institution in Austria. METHODS One hundred and forty-two patients treated for Ewing's sarcoma between 1949 and 1994 were reviewed. Median follow-up was 8.5 years. Fifty-six patients were treated between 1949 and 1980 (group 1), and 86 patients between 1981 and 1994 (group 2… CONTINUE READING

From This Paper

Topics from this paper.


Publications citing this paper.
Showing 1-10 of 14 extracted citations

Prediction of response and prognostic factors for Ewing family of tumors in a low incidence population

Journal of Cancer Research and Clinical Oncology • 2007
View 7 Excerpts
Highly Influenced

Outcomes and prognostic factors for Ewing-family tumors of the extremities.

The Journal of bone and joint surgery. American volume • 2014

Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2010

Similar Papers

Loading similar papers…